| Particulars |
| Company Name |
Cohance Lifesciences Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
38.26 |
B.V. Rs |
60.90 |
| Sales Rs Cr. |
1,093.51 |
NP Rs Cr. |
271.77 |
| NP Var% |
-8.00 |
Div% |
0.00 |
| CPS Rs |
8.60 |
EPS Rs |
7.10 |
| Traded Value(Rs Lakhs) |
106.65 |
52 Week High |
1,359.00 |
| 52 Week Low |
722.00 |
Price BSE |
724.00 |
| Price NSE |
724.00 |
Market Capital(Rs Cr.) |
27,686.38 |
| P/C Ratio |
84.20 |
P/E Ratio |
101.90 |
| Price Vs.BV |
11.89 |
|
| Latest Quarter |
| Year End |
202506 |
Sales Rs Cr. |
483.58 |
| NP Rs Cr. |
58.56 |
NP Var % |
-22.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
914.50 |
| OPM |
38.18 |
NP |
247.20 |
| NP Var% |
38.03 |
EPS |
9.23 |
| PE |
78.41 |
|
|